Does precursor regulation make a difference?

Addiction

Volumn 98, Issue 9, 2003, Pages 1177-1179

  Reuter, Peter ^a,b   Caulkins, Jonathan P ^b,c  

^a UNIVERSITY OF MARYLAND   (United States)

^b RAND CORPORATION   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; CANNABIS; COCAINE; DIAMORPHINE; ILLICIT DRUG; METHAMPHETAMINE;

ARRESTEE DRUG ABUSE MONITORING; COST BENEFIT ANALYSIS; DRUG ABUSE; DRUG ABUSE WARNING NETWORK; DRUG MONITORING; DRUG USE; EDITORIAL; FOLLOW UP; HOSPITALIZATION; INCIDENCE; LAW ENFORCEMENT; MARKET; MARKETING; NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE; REGULATORY MECHANISM; SOCIAL ASPECT; STATISTICAL ANALYSIS; TIME SERIES ANALYSIS; UNITED STATES;

DRUG AND NARCOTIC CONTROL; EPHEDRINE; HUMANS; LEGISLATION, DRUG; METHAMPHETAMINE; SUBSTANCE-RELATED DISORDERS;

EID: 0042835513     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.2003.00483.x     Document Type: Editorial

References (6)

1. Cunningham, J. & Liu, L.-M. (2003) Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions. Addiction, 98, 000-000.
2. Hyatt, R. & Rhodes, W. (1995) The price and purity of cocaine: the relationship to emergency room visits, deaths and to drug use among arrestees. Statistics in Medicine, 14, 655-658.
3. Kopstein, A. (1992) Drug abuse related emergency room episodes in the United States. British Journal of Addiction, 87, 1071-1075.
4. Office of National Drug Control Policy (ONDCP) (2000) What America's Users Spend on Illicit Drugs, 1988-98, Washington, DC: ONDCP.
5. Office of National Drug Control Policy (ONDCP) (2001) The Price of Illicit Drugs, 1981-Second Quarter 2000. Washington, DC: ONDCP.
6. Substance Abuse and Mental Health Services Administration (SAMHSA) (2002) Selected Prevalence Tables. Rockuille, MD: SAMHSA.